Picture of HeartSciences logo

HSCS — HeartSciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Heartsciences' Myovista Technology Used To Develop Ai-ECG Algorithm To Identify Patients At Risk Of Adverse Cardiovascular Events

Nov 10 (Reuters) - Heart Test Laboratories Inc  HSCS.O :
    * HEARTSCIENCES' MYOVISTA® TECHNOLOGY USED TO DEVELOP AI-ECG
ALGORITHM TO IDENTIFY PATIENTS AT HIGH-RISK OF MAJOR ADVERSE
CARDIOVASCULAR EVENTS

Source text for Eikon:  ID:nGNEb881Hf 
Further company coverage:  HSCS.O 
 ((reuters.briefs@thomsonreuters.com;))

Recent news on HeartSciences

See all news